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Abstract
Guttate psoriasis is a less common
form of psoriasis. It manifests with
numerous small, teardrop shaped,
scaly plaques on the trunk and
extremities. The etiology includes both
environmental and genetic factors. It
commonly arises 3-4 weeks following
a beta hemolytic streptococcal
infection. In some cases, it may be
misdiagnosed as an allergy to the
antibiotics being used to treat the
streptococcal infection. The treatment
of guttate psoriasis can vary by
severity, but the mainstay treatment
includes photo therapy and topical
steroids. This case report presents the
etiology, clinical findings and current
treatment options of guttate psoriasis.
It also discusses importance of
differentiating guttate psoriasis from
an antibiotic allergy. The confusion
between the two can often delay and
make treatment more difficult.

Introduction
Psoriasis is a common skin
condition affecting 2% of the
general population. It presents
as erythematous plaques due
to the infiltration of inflammatory
cells and increased proliferation
of keritinocytes.1 It has multiple
variants such as plaque, guttate,
inverse, erythrodermic, and
pustular. Plaque psoriasis is the
most common and most chronic.
Plaque psoriasis presents with
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red, scaly, circular- oval plaques
located over the extensor surfaces
and scalp. It is a chronic relapsing
inflammatory condition with a strong
familial predisposition.2 Guttate
psoriasis is a less common form
of psoriasis, with a prevalence
of less than 30% of patients with
psoriasis. It presents with numerous,
small teardrop shaped plaques
on the trunk and extremities.
Guttate psoriasis often follows
a beta hemolytic streptococcal
upper respiratory tract infection.
The plaques usually develop
3-4 weeks after the infection.3
Post-streptococcal rashes can
be seen and can be difficult to
determine the etiology. Common
rashes seen after beta-hemolytic
streptococcal infections include
scarlet fever, drug eruption, and
guttate psoriasis.4 It is important to
differentiate between the rashes
because treatment options as
well as outcome vary widely.
Symptoms, clinical findings and
timing are important characteristics
to consider when choosing
from a differential diagnosis.

Case Report
A 53-year-old Caucasian
female with no history of psoriasis
presented with sore throat, fever
and chills for 24 hours. On physical
exam, she was febrile (101F) and
in no acute distress. She had
oropharyngeal erythema, exudate,
and swollen tonsils. She had normal
rate and rhythm, normal S1 and
S2, without murmurs. No swollen
lymph nodes were appreciated.
A rapid strep antibody test was
preformed and was positive for
beta hemolytic streptococcus.
She was started on amoxicillin
875MG oral twice daily for 7 days.
One week later, she was still
complaining of sore throat and
tender lymph nodes on the left
side of her neck. Per the patient,
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her symptoms only improved to
90%. On physical exam, she was
afebrile (98F), had oropharyngeal
erythema, but no exudate and no
swollen tonsils. She had anterior
chain tenderness and enlarged
anterior chain lymphadenopathy
on the left side. Since her condition
improved by 90% on amoxicillin,
we extended the course of
antibiotics for 5 more days.
Five days after finishing the
antibiotics, she developed a
rash on her legs that spread to
her torso within one day. At this
point, she phoned her primary
care physician and explained her
symptoms. It was non-puritic,
erythematous and raised. At this
point, “amoxicillin allergy” was added
to the patient’s medical record
and she was instructed to come
in if her symptoms worsened.
The rash persisted for another 3.5
weeks on the trunk and legs, and
she returned to her primary care
physician. Some of the areas began
to change and look scaly, “like they
were drying up” but some had new
erythematous areas, which were
mildly puritic. On physical exam,
she had multiple papulosquamous,
5mm lesions over torso and proximal
extremities, sparing the hands and
feet (Figure 1, 2). A diagnosis of
Guttate Psoriasis was given and
CBC with diff, CCP and RPR were
ordered along with a dermatology
referral. The CBC with diff was within
normal limits and RPR was negative.
CCP was within normal limits,
except for a globulin level of 3.6gm/
dl and a total protein of 8.4gm/dl.
The dermatologist confirmed the
diagnosis of guttate psoriasis.
The patient was treated with
triamcinolone acetonide Cream 0.1%
application twice daily for 3 weeks.
She was also instructed to get as
much natural sunlight as possible
without burning. Treament with
PUVA (psoralen + UVA treatment)
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was considered, however, at a threemonth follow-up with her primary
care doctor, her psoriasis was
resolving, and at one-year followup, it was completely resolved.

Discussion
Our patient presented with a rash
2.5 weeks after she was diagnosed
with strep throat. Initially, the etiology
of her rash was unclear. Due to the
frequency of drug-induced allergic
reactions and failure to visualize the
rash, she was misdiagnosed with
an allergy. Amoxicillin is a penicillin
derivate and one of the most
common causes of drug-induced
allergic reaction. Antihistamines
and systemic corticosteroids are
recommended for the treatment
of drug-induced allergic reactions;
however, many times withdrawal
of the drug will suffice.5
A drug eruption caused by
amoxicillin commonly presents
8-10 days after initiating treatment.
It manifests as a combination of
macules and papules and usually

become confluent affecting large
areas of the body.5 When the rash
was visualized 3.5 weeks later,
it displayed the classic clinical
findings of guttate psoriasis. The
rash presented approximately
2.5 weeks after the diagnosis
of strep throat and had the
characteristic distribution to the
trunk and extremities and the
classic tear drop appearance.
The etiology of guttate psoriasis
includes both environmental and
genetic components. The genetic
component has been located in the
MHC region of chromosome 6p21.3
where the psoriasis susceptibility
locus (PSORS)1 resides.6 This area
is thought to house the psoriasis
gene. HLA-Cw0602, an allele of
the HLA-C gene has been found
to have the strongest association
with psoriasis phenotype. However,
it is important to note that not all
HLA-Cw0602 positive individuals
develop psoriasis and more
than 30% of psoriasis patients
are HLA-Cw0602 negative.6

T cells are thought to play a
critical role in the pathogenesis
of guttate psoriasis. Proposed
mechanisms for the relationship of
post-streptococcal guttate psoriasis
have been postulated. Examples
include cross reactivity between
streptococcal M proteins presented
to immune cells in the tonsils and
structurally similar type I keratins
in the epidermis trigger a T cell
mediated autoimmune reaction.
In addition, recent studies have
demonstrated that streptococcal M
proteins and streptococcal pyrogenic
exotoxins act as superantigens,
which cause a marked expansion
of both CD4+, and CD8+ T cells.1
Evidence of the T cell involvement
is seen in the effective treatment
with immunosuppressive drugs
which inhibit the T cell activation and
cytokine secretion such as anti-CD3,
corticosteroids, and cyclosporine A.1
Guttate psoriasis may
spontaneously remit within
several weeks to months, it may
intermittently reoccur, or may persist
and progress to chronic plaque
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Figure 1. Lesions covering patient’s upper back

however, data is insufficient to
recommend routine tonsillectomy.
Systemic antibiotic therapy
should be used to treat active
streptococcal infection; however,
little evidence shows efficacy in
using systemic antimicrobials
for the skin involvement.7
It is important not to treat
guttate psoriasis with systemic
corticosteroids due to the
rebound flare phenomenon. They
may temporarily show signs of
improvement; however, severe
rebound attacks occur when the
dose is removed, reduced, or even
maintained.8 The rebounds tend to
be worse than the initial eruption,
and can be life threatening. The
rebound attack is often unresponsive
to any form of treatment.8

Figure 2. Closer view of lesions on patient’s upper back

Conclusion
Guttate psoriasis is important
for primary care physicians to
recognize and treat appropriately.
Due to its common presentation
after a streptococcal infection and
probable completion of antibiotic
therapy, it is important not to confuse
guttate psoriasis with an antibiotic
allergy due to the treatment of the
allergy worsening the psoriasis.
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